Phys Clinical Cases · general-medicine
Anaphylaxis — DCE Clinical Case
DCE long-case station: post-anaphylaxis review of a young woman with two reactions in eight months — history reconstruction, examination for triggers and comorbidity, and a management plan covering device, plan, referral and cofactor control, with presentation template and probing questions.
4 min readVerification in progress
On this page
Study tools
Target exams
FRACP DCEMRCP Part 2
Prompt
DCE long-case station: post-anaphylaxis review of a young woman with two reactions in eight months — history reconstruction, examination for triggers and comorbidity, and a management plan covering device, plan, referral and cofactor control, with presentation template and probing questions.
Focused history — what you must establish
- Episode reconstruction, hour by hour: for each episode — everything eaten in the preceding six hours and exactly when, alcohol, exercise before or after eating, NSAIDs or other new medicines, intercurrent illness, insect exposure, menstruation, and the first symptom with its progression [1].
- Severity markers: which systems were involved, whether hypotension or collapse occurred, adrenaline doses required, and whether symptoms recurred after resolution — her second episode needing two doses marks her as a higher-risk phenotype [2].
- The running clue: the second episode during a run after an evening meal raises food-dependent exercise-induced anaphylaxis — ask specifically what she ate before running, and whether the same meal without exercise has ever caused symptoms [6].
- Cofactor and medication audit: regular and intermittent NSAIDs, any ACE inhibitor or beta-blocker, asthma or eczema history, and alcohol patterns — each amplifies reactions, and the cardiovascular drugs worsen outcomes [2].
- The safety-net gap: what she was actually discharged with, whether she can use the device, what she has been told, and what she now avoids — one device, no training and no plan is the commonest systems failure in this case [1].
- Her frame: food anxiety, fear around running, and what she most wants to be able to do safely.
References6ShowHide
- [1]Campbell RL, Li JT, Nicklas RA, et al. Emergency department diagnosis and treatment of anaphylaxis: a practice parameter Ann Allergy Asthma Immunol, 2014.PMID 25466802
- [2]Turner PJ, Jerschow E, Umasunthar T, et al. Fatal Anaphylaxis: Mortality Rate and Risk Factors J Allergy Clin Immunol Pract, 2017.PMID 28888247
- [3]Schwartz LB Diagnostic value of tryptase in anaphylaxis and mastocytosis Immunol Allergy Clin North Am, 2006.PMID 16931288
- [4]Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal Int Arch Allergy Immunol, 2012.PMID 22041891
- [5]Boyle RJ, Elremeli M, Hockenhull J, et al. Venom immunotherapy for preventing allergic reactions to insect stings Cochrane Database Syst Rev, 2012.PMID 23076950
- [6]Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology Allergy, 2014.PMID 24909803